| NCT ID | NCT06766006 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Maastricht University Medical Center |
| Condition | Shock, Cardiogenic |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2026-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2024-04-01 with a primary completion date of 2026-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The present study is an International multicentric prospective observational cohort study. This will be an international research campaign to prospectively collect and analyze clinical data of all VA ECLS patients admitted to participating ICUs with a focus on LV venting modalities. The aims of the study are: * To investigate the meaning of LV overload during veno-arterial (VA) extracorporeal life support; * To extensively describe the left ventricular (LV) unloading strategy during VA extracorporeal life support in a large prospective international cohort. * To compare different strategies to unload the left ventricular in terms of efficacy and outcomes;
Eligibility Criteria
Inclusion Criteria: * All patients undergoing VA ECLS will be enrolled. Exclusion Criteria: * Patients without VA ECMO will not be considered
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06766006 clinical trial?
This trial is open to participants of all sexes, aged 1 Day or older, up to 80 Years, studying Shock, Cardiogenic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06766006 currently recruiting?
Yes, NCT06766006 is actively recruiting participants. Contact the research team at paolo.meani@mumc.nl for enrollment information.
Where is the NCT06766006 trial being conducted?
This trial is being conducted at Maastricht, Netherlands.
Who is sponsoring the NCT06766006 clinical trial?
NCT06766006 is sponsored by Maastricht University Medical Center. The trial plans to enroll 500 participants.